Lombard Medical, Inc.

EVARF

KYG555981094

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 06:40:00 29/11/2023 am IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2017	Lombard Medical, Inc.(NasdaqCM:EVAR) dropped from NASDAQ Composite Index	CI
2017	Lombard Medical, Inc. Announces Unaudited Earnings Results for the Third Quarter Ended September 30, 2017; Provides Earnings Guidance for the Fourth Quarter of 2017 and Fiscal Year 2018	CI

Lombard Medical, Inc. Announces Resignation of William J. Kullback as Chief Financial Officer, Effective May 5, 2017

April 28, 2017 at 03:38 pm IST

Effective May 5, 2017, Mr. William J. Kullback resigned as the Chief Financial Officer of Lombard Medical, Inc. to pursue a new opportunity at a San Diego, California based corporation.

Latest news about Lombard Medical, Inc.

Lombard Medical, Inc.(NasdaqCM:EVAR) dropped from NASDAQ Composite Index	08/17/08	CI
Lombard Medical, Inc. Announces Unaudited Earnings Results for the Third Quarter Ended September 30, 2017; Provides Earnings Guidance for the Fourth Quarter of 2017 and Fiscal Year 2018	31/17/31	CI
Lombard Medical, Inc. Announces Full Commercial Launch of Japan of its New Low-Profile IntelliFlex LP Delivery System for the Aorfix AAA System	26/17/26	CI
Lombard Medical, Inc. Appoints Jonathan Hornsby as Vice President, Sales & Marketing	20/17/20	CI
Lombard Medical, Inc. Announces Resignation of William J. Kullback as Chief Financial Officer, Effective May 5, 2017	28/17/28	CI
Lombard Medical, Inc. Appoints Kurt Lemvigh as CEO	20/17/20	CI
Lombard Medical, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016; Reports Impairment-Goodwill and Long-Lived Intangibles for the Fourth Quarter of 2016	18/17/18	CI
Simon Hubbert Steps Down from Lombard Medical, Inc. as CEO	18/17/18	CI
Lombard Medical, Inc. and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements	03/17/03	CI
Lombard Medical, Inc. Announces Board Changes	19/16/19	CI
Lombard Medical, Inc. and MicroPort Scientific Corporation Announce Strategic Partnership	19/16/19	CI
Lombard Medical, Inc. announced that it has received $15 million in funding from MicroPort NeuroTech Co., Ltd., MicroPort NeuroTech CHINA Corp. Limited	18/16/18	CI
Lombard Medical, Inc. Announces Positive Long-Term Data for Aorfix™	05/16/05	CI
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016	28/16/28	CI
Lombard Medical, Inc. Wins GBP 202.7 Million Multiple Awardees Contract	27/16/27	CI
Invesco Intends to Engage in Discussions with Lombard Medical	16/16/16	CI
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	23/16/23	CI
Lombard Medical Seeks Strategic Alternatives	22/16/22	CI
Lombard Medical, Inc. Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft	20/16/20	CI
Lombard Medical, Inc. Plans to Conduct 1,000 Patient Global Registry to Evaluate New Altura Endograft System	16/16/16	CI
Lombard Medical, Inc. Announces Positive Clinical Results from The Prospective Aneurysm Trial	13/16/13	CI
Lombard Medical Receives Australian Therapeutic Goods Administration Approval for the Aorfix Endovascular Stent Graft for the Treatment of Abdominal Aortic Aneurysms	06/16/06	CI
Lombard Medical, Inc. Announces Consolidated Unaudited Financial Results for the First Quarter Ended March 31, 2016; Provides Revenue Guidance for the Year 2016	12/16/12	CI
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015; Provides Revenue Guidance for 2016	22/16/22	CI
Lombard Medical, Inc. Announces Preliminary Revenue for the Fourth Quarter and Full Year 2015; Announces Launch of Altura Aaa Product Line and Aorfix Intelliflex LP Delivery System	12/16/12	CI

Lombard Medical, Inc. is a medical device company. The Company is focused solely on the minimally invasive treatment of aortic disease. The Company partners with MicroPort Endovastec to offer Minos abdominal aortic aneurysm (AAA) stent-graft, the Hercules TAA stent graft and the Castor Branched Thoracic stent graft, in addition to its own Aorfix and Altura stent grafts. The Companyâs products include Minos, Aorfix, Altura, Meridian, Hercules, Castor, and Hercules Balloon.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
LOMBARD MEDICAL, INC.	-.--%	27
THERMO FISHER SCIENTIFIC	+12.06%	227B
DANAHER CORPORATION	+12.07%	192B
INTUITIVE SURGICAL, INC.	+13.88%	136B
BOSTON SCIENTIFIC CORPORATION	+27.12%	108B
SIEMENS HEALTHINEERS AG	+0.38%	64.07B
EDWARDS LIFESCIENCES CORPORATION	+13.39%	52.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.74%	51.87B
AGILENT TECHNOLOGIES, INC.	+8.81%	44.33B
GE HEALTHCARE TECHNOLOGIES INC.	+4.14%	36.75B

Other Advanced Medical Equipment & Technology